|
2019
|
Invention
|
Method for treating inflammatory disorders.
The present invention relates to a method for suppre... |
|
2018
|
Invention
|
Combination therapy of hsp90 inhibitors with platinum-containing agents. A pharmaceutical combina... |
|
2017
|
Invention
|
Combination therapy of hsp90 inhibitory compounds with chk inhibitors.
A pharmaceutical composit... |
|
|
Invention
|
Combination therapy for treatment of ovarian cancer. This invention relates to methods of treatin... |
|
2016
|
Invention
|
Combination therapy of hsp90 inhibitors and pd-1 inhibitors for treating cancer. A pharmaceutical... |
|
2015
|
Invention
|
Triple combination therapy, comprising ganetespib, a taxane and an antibody, for use in the treat... |
|
|
Invention
|
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor.
A pharm... |
|
|
P/S
|
pharmaceutical products, namely, drugs for inflammatory diseases and cancer. pharmaceutical drug ... |
|
|
Invention
|
Tricyclic triazole compounds that modulate hsp90 activity.
The present invention relates to subs... |
|
|
Invention
|
Triazole compounds that modulate hsp90 activity.
The present invention relates to substituted tr... |
|
|
Invention
|
Paclitaxel enhancer compounds.
Disclosed is a compound represented by the Structural Formula (I)... |
|
|
Invention
|
Imidazole compounds that modulate hsp90 activity.
Compounds of formula (I), pharmaceutical compo... |
|
|
Invention
|
Targeted therapeutics. The present invention provides pharmacological compounds including a pepti... |
|
|
Invention
|
Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitory compound based on ch... |
|
|
Invention
|
Triazole compounds that modulate hsp90 activity. The present invention relates to substituted tri... |
|
|
Invention
|
Cancer therapy with ganetespib and an egfr inhibitor. Methods of treating cancer with ganetespib ... |
|
|
P/S
|
pharmaceutical preparations for the treatment of cancer. |
|
|
Invention
|
Targeted therapeutics. The present invention provides pharmacological compounds including an effe... |
|
|
Invention
|
Method for inhibiting topoisomerase ii.
The present invention relates to compounds that inhibit ... |
|
|
Invention
|
Formulation and dosing of hsp90 inhibitory compounds.
Provided is a pharmaceutical composition c... |
|
|
Invention
|
Targeted cancer treatment by hsp90 inhibitors ganetespib and nvp-auy922.
Methods of treating cer... |
|
|
Invention
|
Targeted cancer treatment by hsp90 inhibitors ganetespib and nvp-auy922. Methods of treating cert... |
|
2014
|
Invention
|
Method for treating proliferative disorders associated with protooncogene products.
The present ... |
|
|
Invention
|
Treating cancer with hsp90 inhibitory compounds.
Methods of treating cancer with a compound of f... |
|
|
Invention
|
Method for treating b cell regulated autoimmune disorders.
The invention relates to a method for... |
|
|
Invention
|
Pre-selection of subjects for therapeutic treatment with an hsp90 inhibitor based on hypoxic stat... |
|
|
Invention
|
Transition metal complexes of a bis[thiohydrazide amide] compound.
The present invention is dire... |
|
|
Invention
|
Compounds for the treatment of proliferative disorders. Disclosed are compounds and pharmaceutica... |
|
|
Invention
|
Pyrrole compounds that modulate hsp90 activity. The present invention relates to substituted pyrr... |
|
|
Invention
|
Specific cancer treatment regimes with ganetespib.
Methods of treating certain types of cancer w... |
|
|
Invention
|
Specific cancer treatment regimens with ganetespib. Methods of treating certain types of cancer w... |
|
|
Invention
|
Compounds for treating proliferative disorders.
Disclosed are compounds and methods of using com... |
|
|
Invention
|
Compounds that modulate hsp90 activity and methods for identifying same.
The present invention r... |
|
|
Invention
|
Polymorphs of n-malonyl-bis(n′-methyl-n′-thiobenzoylhydrazide). At least 70% by weight of Compoun... |
|
2013
|
Invention
|
Compounds for treating proliferative disorders. Disclosed are compounds of formulae (I), (III), (... |
|
|
Invention
|
Treating polycystic kidney disease with hsp90 inhibitory compounds.
Provided are methods of trea... |
|
|
Invention
|
Compounds for inflammation and immune-related uses.
The invention relates to compounds of formul... |
|
|
Invention
|
Treating cancer with hsp90 inhibitory compounds.
A method for treating cancer with a mutation in... |
|
|
Invention
|
Novel triazole compounds that modulate hsp90 activity.
The present invention relates to novel tr... |
|
|
Invention
|
Triazole derivatives as hsp90 inhibitors.
A compound of structural formula (I) or (II): as HSP90... |
|
2012
|
Invention
|
Administration of a bis(thiohydrazide amide) compound for treating cancers.
Administration of a ... |
|
2005
|
P/S
|
PHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES, AND CANCER |
|
|
P/S
|
PHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES AND CANCER |
